Ionis Pharmaceuticals (IONS) Amortizatization of Intangibles (2014 - 2026)

Ionis Pharmaceuticals' Amortizatization of Intangibles history runs 13 years deep, the most recent figure standing at $6.2 million for Q1 2026.

• On a quarterly basis, Amortizatization of Intangibles fell 12.92% year-over-year to $6.2 million in Q1 2026; TTM through Mar 2026 was $22.8 million, a 35.88% decrease from a year earlier, with the FY2025 full-year figure at $23.7 million, down 37.1% from the prior year.
• Amortizatization of Intangibles grew to $6.2 million in Q1 2026 per IONS's latest filing, from $5.7 million in the prior quarter.
• Across five years, Amortizatization of Intangibles topped out at $9.9 million in Q2 2024 and bottomed at -$4.2 million in Q1 2022.
• The 5-year median for Amortizatization of Intangibles is $6.2 million (2026), against an average of $5.2 million.
• Across the five-year window, Amortizatization of Intangibles jumped 756.85% in 2023 and plunged 44.37% in 2025, its largest moves.
• Year by year, Amortizatization of Intangibles stood at $1.7 million in 2022, then surged by 404.4% to $8.5 million in 2023, then climbed by 11.32% to $9.4 million in 2024, then slumped by 39.98% to $5.7 million in 2025, then climbed by 9.13% to $6.2 million in 2026.
• Per Business Quant, the three latest IONS Amortizatization of Intangibles figures stand at $6.2 million (Q1 2026), $5.7 million (Q4 2025), and $5.1 million (Q3 2025).